$61.6 M

ALIM Mkt cap, 22-Jun-2018

$9.8 M

Alimera Sciences Revenue Q1, 2018
Alimera Sciences Net income (Q1, 2018)-7.7 M
Alimera Sciences Cash, 30-Jun-201726.9 M

Alimera Sciences Financials

Alimera Sciences Income Statement

Annual

USDFY, 2013FY, 2014FY, 2015FY, 2016

Revenue

1.9 m8.4 m22.4 m34.3 m

Revenue growth, %

350%166%53%

Cost of goods sold

1.9 m

Gross profit

9 k

Gross profit Margin, %

0%

Sales and marketing expense

29.4 m

General and administrative expense

15.3 m

Operating expense total

44.7 m

EBIT

(46.2 m)(32.9 m)(39 m)(27.8 m)

EBIT margin, %

(2469%)(391%)(174%)(81%)

Net Income

(46.2 m)(35.9 m)(30.6 m)(33.2 m)

Quarterly

USDQ3, 2013Q1, 2014Q2, 2014Q3, 2014Q1, 2015Q2, 2015Q3, 2015Q1, 2016Q2, 2016Q3, 2016Q1, 2017Q2, 2017Q1, 2018

Revenue

758 k2.1 m2.2 m2.4 m3.9 m5.8 m6.9 m5.8 m9.6 m8.3 m6.6 m10.4 m9.8 m

Cost of goods sold

57 k564 k376 k

Gross profit

701 k1.5 m1.8 m

Gross profit Margin, %

92%73%83%

Sales and marketing expense

4.5 m3.4 m3.1 m3.7 m7.1 m6.9 m6.9 m7.1 m7.5 m7.5 m5.5 m5.1 m6 m

R&D expense

1.8 m2.6 m1.8 m3.9 m3.3 m

General and administrative expense

2.1 m2.9 m2.8 m3 m3.6 m3.8 m3 m3.4 m4 m3.6 m3.3 m3 m3.9 m

Operating expense total

8.4 m9 m7.8 m10.6 m14.1 m10.7 m10 m10.5 m11.5 m11.1 m8.8 m8.1 m9.8 m

Depreciation and amortization

649 k

EBIT

(11 m)(9.8 m)(8.4 m)(8.8 m)(6.4 m)(7.2 m)(5.5 m)(1.4 m)

EBIT margin, %

(279%)(170%)(122%)(152%)(67%)(87%)(83%)(13%)

Net Income

(1.1 m)(20.8 m)1.1 m(7 m)(9.8 m)(18.4 m)(19.9 m)(11.1 m)(18 m)(27.2 m)(6.7 m)(2.8 m)(7.7 m)

Alimera Sciences Balance Sheet

Annual

USDFY, 2013FY, 2014FY, 2015FY, 2016

Cash

12.6 m76.7 m31.1 m31 m

Accounts Receivable

500 k850 k9.8 m13.8 m

Inventories

3.5 m3.2 m2.7 m446 k

Current Assets

18.6 m83.3 m45.2 m47.4 m

Total Assets

19.6 m109.4 m70.5 m70.2 m

Accounts Payable

1.7 m5 m4 m5 m

Current Liabilities

4.9 m10.5 m39.9 m9.1 m

Additional Paid-in Capital

240.1 m292.9 m299.4 m330.8 m

Retained Earnings

(277.3 m)(313.3 m)(343.9 m)(377.1 m)

Total Equity

26.3 m25.6 m

Financial Leverage

2.7 x2.7 x

Quarterly

USDQ3, 2013Q1, 2014Q2, 2014Q3, 2014Q1, 2015Q2, 2015Q3, 2015Q1, 2016Q2, 2016Q3, 2016Q1, 2017Q2, 2017

Cash

23.1 m41.3 m42 m61.4 m61.3 m48.1 m39.3 m23.9 m16.6 m33.9 m26.7 m26.9 m

Accounts Receivable

464 k1.3 m1 m1.1 m3.4 m7.7 m9.4 m9.1 m13.3 m13.4 m10.8 m13.6 m

Inventories

3 m1.2 m1.4 m1.7 m2.1 m1.6 m1.7 m1.4 m1.2 m913 k802 k1.1 m

Current Assets

30.1 m46.5 m47.5 m67.3 m70.3 m61.1 m53.4 m37.2 m34.7 m51.6 m40.5 m44.3 m

PP&E

1 m2.5 m2.7 m2.6 m2.5 m2.3 m2.1 m1.6 m1.5 m

Total Assets

30.5 m47.4 m48.7 m93.3 m96.8 m87.3 m79 m62 m58.8 m75 m62.6 m65.9 m

Accounts Payable

2.7 m1.8 m1.9 m2.9 m4.7 m3.3 m3.1 m3.9 m5.7 m3.4 m4 m5.7 m

Short-term debt

1.5 m

Current Liabilities

7.3 m4.5 m4.2 m32 m12 m15 m6.7 m42.4 m45.2 m7.9 m6.8 m9.6 m

Long-term debt

1.5 m

Total Debt

3.1 m

Additional Paid-in Capital

239.2 m276.6 m282.4 m291.7 m294.1 m295.3 m296.9 m300.7 m302.5 m329.5 m331.9 m336.1 m

Retained Earnings

(262.6 m)(298.1 m)(297 m)(304 m)(323 m)(331.6 m)(333.2 m)(355 m)(361.9 m)(371.1 m)(383.8 m)(386.6 m)

Total Equity

33.3 m33.4 m16.9 m11.8 m30 m20.1 m21.7 m

Financial Leverage

2.6 x2.4 x3.7 x5 x2.5 x3.1 x3 x

Alimera Sciences Cash Flow

Annual

USDFY, 2013FY, 2014FY, 2015FY, 2016

Net Income

(46.2 m)(35.9 m)(30.6 m)(33.2 m)

Depreciation and Amortization

138 k659 k2.6 m2.8 m

Accounts Receivable

(483 k)(444 k)(8.9 m)(4.1 m)

Inventories

(1.4 m)206 k405 k1 m

Accounts Payable

(259 k)3 m(487 k)1.1 m

Cash From Operating Activities

(37.8 m)(24.3 m)(45.4 m)(25.1 m)

Purchases of PP&E

(973 k)(842 k)(451 k)(186 k)

Cash From Investing Activities

(973 k)(25.8 m)(451 k)(186 k)

Cash From Financing Activities

1.7 m114.7 m625 k25.4 m

Interest Paid

607 k1.2 m4.2 m4 m

Income Taxes Paid

263 k193 k

Quarterly

USDQ3, 2013Q1, 2014Q2, 2014Q3, 2014Q1, 2015Q2, 2015Q3, 2015Q1, 2016Q2, 2016Q3, 2016Q1, 2017Q2, 2017Q1, 2018

Net Income

(31.5 m)(20.8 m)(19.6 m)(26.7 m)(9.8 m)(18.4 m)(19.9 m)(11.1 m)(18 m)(27.2 m)(6.7 m)(9.5 m)(7.7 m)

Depreciation and Amortization

101 k36 k69 k151 k558 k1.2 m1.9 m689 k1.4 m2.1 m666 k1.3 m649 k

Accounts Receivable

(451 k)(775 k)(526 k)(679 k)(2.7 m)(6.8 m)(8.5 m)761 k(3.5 m)(3.6 m)3.1 m337 k(867 k)

Inventories

(2.2 m)548 k400 k(9 k)(455 k)(16 k)(88 k)164 k301 k612 k(361 k)(719 k)299 k

Accounts Payable

717 k111 k122 k1.3 m272 k(1.2 m)(1.4 m)(1.5 m)264 k(2.1 m)(1.1 m)572 k(992 k)

Cash From Operating Activities

(28.1 m)(6.2 m)(10.2 m)(15.2 m)(14.7 m)(27.7 m)(36.5 m)(6.7 m)(14.2 m)(22.7 m)(4.2 m)(7 m)(5 m)

Purchases of PP&E

(386 k)(12 k)(210 k)(163 k)(160 k)(337 k)(370 k)(75 k)(116 k)(122 k)(57 k)(167 k)(91 k)

Cash From Investing Activities

(386 k)(12 k)(210 k)(163 k)(160 k)(337 k)(370 k)(75 k)(116 k)(122 k)(57 k)(167 k)(91 k)

Cash From Financing Activities

1.8 m35 m39.7 m64.7 m(205 k)(297 k)(214 k)(466 k)(158 k)25.6 m(38 k)2.9 m1.2 m

Interest Paid

511 k89 k224 k502 k954 k1.9 m2.9 m996 k2 m3 m985 k2 m932 k

Income Taxes Paid

9 k13 k263 k299 k11 k55 k
Report incorrect company information